Shui AM, Kaat AJ, Ghods SS, Farmer CA, Thurm A, Georgiades S, Kanne SM, Esler AN, Kim YS, Lord C, Bishop SL. Effect of Sex on Autism Diagnostic Instrument Scores. International Society for Autism Research (INSAR) Annual Meeting, Montreal, Quebec, Canada, 2019.

Shui AM, Katz T, Bal VH. Understanding Pediatric Quality of Life in Autism Spectrum Disorder: Variability in Dimensions in Children with Varying Language Levels. International Society for Autism Research (INSAR) Annual Meeting, Montreal, Quebec, Canada, 2019.

Shui AM, Katz T, Malow BA, Mazurek MO. Association between Sleep Problems and Aggressive Behavior, Attention Problems, and Internalizing Behaviors Using Baseline and Follow-up Data in the Autism Speaks-Autism Treatment Network Registry.
International Society for Autism Research (INSAR) Annual Meeting, Rotterdam, Netherlands, 2018.

Shui AM, Katz T, Malow BA, Mazurek MO. Predicting Parent-Reported Sleep Problems Using Longitudinal Data and Machine Learning in the Autism Speaks-Autism Treatment Network Registry. International Meeting for Autism Research (IMFAR), San Francisco, CA, USA, 2017.

Healy B, Shui A, Hayden D. Developing Online Resources to Teach Biostatistics to Working Medical Researchers. Joint Statistical Meetings (JSM), Seattle, WA, USA, 2015.

Shui AM, Malow BA, Katz T. Item Analysis of the Children’s Sleep Habits Questionnaire in the Autism Speaks-Autism Treatment Network Registry Data. SLEEP, Seattle, WA, USA, 2015.

Shui A, Fedele A. The Autism Speaks Autism Treatment Network (AS ATN) Registry Data: Opportunities for Investigators. American Academy of Child & Adolescent Psychiatry (AACAP), San Diego, CA, USA, 2014 and International Autism Conference, Antalya, Turkey, 2014.

Hirota T, Bishop S, Adachi M, Shui A, Takahashi M, Mori H, Nakamura K. Utilization of the maternal and child health handbook in early identification of autism spectrum disorder and other neurodevelopmental disorders. Autism Research. 2020.

Fava M, Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, et al. Double-blind placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Ann Clin Psychiatry. 2020 Nov 01; 32(4):e16-e24.

Fenning RM, Steinberg-Epstein R, Butter EM, Chan J, McKinnon-Bermingham K, Hammersmith KJ, Moffitt J, Shui AM, et al. Access to dental visits and correlates of preventive dental care in children with autism spectrum disorder. J Autism Dev Disord. 2020 Oct; 50(10):3739-3747.

Naoum GE, Roberts S, Brunelle CL, Shui AM, Salama L, Daniell K, Gillespie T, Bucci L, Smith BL, Ho AY, Taghian AG. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020 Jul 30; JCO2000459.

Brunelle CL, Roberts SA, Shui AM, Gillespie TC, Daniell KM, Naoum GE, Taghian A. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: results from a large prospective screening cohort. J Surg Oncol. 2020 Jun.

Saito M, Hirota T, Sakamoto Y, Adachi M, Takahashi M, Osato-Kaneda A, Kim YS, Leventhal B, Shui A, Kato S, Nakamura K. Prevalence and cumulative incidence of autism spectrum disorders and the patterns of co-occurring neurodevelopmental disorders in a total population sample of 5-year old children. Mol Autism. 2020 May;11(1):35.

Kaat AJ, Shui AM, Ghods SS, Farmer CA, Esler AN, Thurm A, Georgiades S, Kanne SM, Lord C, Kim YS, Bishop SL. Sex differences in scores on standardized measures of autism symptoms: a multisite integrative data analysis. Child Psychol Psychiatry. 2020 Apr.

Lindly OJ, Crossman MK, Shui AM, Kuo DZ, Earl KM, Kleven AR, Perrin JM, Kuhlthau KA. Healthcare access and adverse family impact among U.S. children ages 0-5 years by prematurity status. BMC Pediatr. 2020 Apr;20(1):168.

Fenning RM, Steinberg-Epstein R, Butter EM, Chan J, McKinnon-Bermingham K, Hammersmith KJ, MoffittJ, Shui AM, Parker RA, Coury DL, Wang PP, Kuhlthau KA. Access to dental visits and correlates of preventive dental care in children with autism spectrum disorder. J Autism Dev Disord. 2020 Feb.

Reynolds AM, Connolly HV, Katz T, Goldman SE, Weiss SK, Halbower AC, Shui AM, Macklin EA, Hyman SL, Malow BA. Randomized, placebo-controlled trial of ferrous sulfate to treat insomnia in children with autism spectrum disorders. 
Pediatr Neurol. 2020 Mar;104:30-39.

Knutsen J, Crossman M, Perrin J, Shui A, Kuhlthau K. Sex differences in restricted repetitive behaviors and interests in children with autism spectrum disorder: An Autism Treatment Network study. Autism. 2019 May;23(4):858-868.

Pathak M, Bennett A, Shui AM. Correlates of adaptive behavior profiles in a large cohort of children with autism: The Autism Speaks Autism Treatment Network registry data. Autism. 2019 Jan;23(1):87-99.

Shui AM, Katz T, Malow BA, Mazurek MO. Predicting sleep problems in children with autism spectrum disorders. Research in Developmental Disabilities. 2018 Dec;83:270-279.

Kallenbach L, Shui AM, Cheng WY, Fan T, Hu W, Zichlin ML, Duh MS, Ye F, Levin PA. Predictors and clinical outcomes of treatment intensification in patients with type 2 diabetes uncontrolled on basal insulin in a real-world setting. Endocr Pract. 2018 Sep;24(9):805-814.

Nipp RD, Shui AM, Perez GK, Kirchhoff AC, Peppercorn JM, Moy B, Kuhlthau K, Park ER. Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act. JAMA Oncol. 2018 Jun 1;4(6):791-797.

Katz T, Shui AM, Johnson CR, Richdale AL, Reynolds AM, Scahill L, Malow BA. Modification of the Children’s Sleep Habits Questionnaire for Children with Autism Spectrum Disorder. J Autism Dev Disord. 2018 Aug;48(8):2629-2641.

Hedgecock JB, Dannemiller LA, Shui A, Rapport MJ, Katz T. Associations of Gross Motor Delay, Behavior, and Quality of Life in Young Children with Autism. Phys Ther. 2018 Apr 1;98(4):251-259.

Paganoni S, Nicholson K, Chan J, Shui A, et al. Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database. Muscle Nerve. 2018 Mar;57(3):430-434.

Loring WA, Johnston R, Shui AM, Malow BA. Impact of brief behavioral intervention for insomnia on daytime behaviors in adolescents with autism spectrum disorders. J Contemp Pyschother. 2018 Jan 29:1-13.

Yu M, Mody R, Lando LF, Shui A, et al. Characteristics Associated with the Choice of First Injectable Therapy Among US Patients with Type 2 Diabetes. Clin Ther. 2017 Dec;39(12):2399-2408.

Flor J, Bellando J, Lopez M, Shui A. Developmental functioning and medical co-morbidity profile of children with complex and essential autism. Autism Res. 2017 Aug;10(8):1344-1352.

Zuckerman KE, Friedman NDB, Chavez AE, Shui AM, Kuhlthau KA. Parent-Reported Severity and Health/Educational Services Use Among US Children with Autism: Results from a National Survey. J Dev Behav Pediatr. 2017 May;38(4):260-268.

Lake JK, Denton D, Lunsky Y, Shui AM, Veenstra-VanderWeele J, Anagnostou E. Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder. J Autism Dev Disord. 2017 May;47(5):1391-1402.

Mody M, Shui AM, Nowinski LA, Golas SB, Ferrone C, O’Rourke JA, McDougle CJ. Communication Deficits and the Motor System: Exploring Patterns of Associations in Autism Spectrum Disorder (ASD). J Autism Dev Disord. 2017 Jan;47(1):155-162.

Kuhlthau KA, Nipp RD, Shui A, et al. Health insurance coverage, care accessibility and affordability for adult survivors of childhood cancer: a cross-sectional study of a nationally representative database. J Cancer Surviv. 2016 Dec;10(6):964-971.

Hundley RJ, Shui A, Malow BA. Relationship Between Subtypes of Restricted and Repetitive Behaviors and Sleep Disturbance in Autism Spectrum Disorder. J Autism Dev Disord. 2016 Nov;46(11):3448-3457.

Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, et al. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People with Autism Spectrum Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Sep 1;73(9):928-37.

Malow BA, Connolly HV, Weiss SK, Halbower A, Goldman S, Hyman SL, Katz T, Madduri N, Shui A, Macklin E, Reynolds AM. The Pediatric Sleep Clinical Global Impressions Scale-A New Tool to Measure Pediatric Insomnia in Autism Spectrum Disorders. J Dev Behav Pediatr. 2016 Jun;37(5):370-6.

Malow BA, Katz T, Reynolds AM, Shui A, Carno M, Connolly HV, Coury D, Bennett AE. Sleep Difficulties and Medications in Children with Autism Spectrum Disorders: A Registry Study. Pediatrics. 2016 Feb;137 Suppl 2:S98-S104.

Ezell J, Shui A, Sanders K, Veenstra-VanderWeele J. Pattern of Diagnosis and Co-occurring Symptoms in Adopted Children with Autism Spectrum Disorder. Pediatrics. 2016 Feb;137 Suppl 2:S90-7.

Murray DS, Fedele A, Shui A, Coury DL. The Autism Speaks Autism Treatment Network Registry Data: Opportunities for Investigators. Pediatrics. 2016 Feb;137 Suppl 2:S72-8.

Broder-Fingert S, Shui A, et al. A Pilot Study of Autism-Specific Care Plans During Hospital Admission. Pediatrics. 2016 Feb;137 Suppl 2:S196-204.

Kuhlthau KA, Delahaye J, Erickson-Warfield M, Shui AM, et al. Health Care Transition Services for Youth with Autism Spectrum Disorders: Perspectives of Caregivers. Pediatrics. 2016 Feb;137 Suppl 2:S158-66.

Greenlee JL, Moseley AS, Shui AM, Veenstra VanderWeele J, Gotham KO. Medical and Behavioral Correlates of Depression History in Children and Adolescents with Autism Spectrum Disorder. Pediatrics. 2016 Feb;137 Suppl 2:S105-14.

Nipp RD, Shui A, Kirchhoff AC, Perez GK, Moy B, Park ER, Kuhlthau K. Financial burden in adult cancer survivors: Care affordability and accessibility. Journal of Clinical Oncology. 2016 May;34(15_suppl):6535-6535.

Gnanasekaran S, Choueiri R, Neumeyer A, Ajari O, Shui A, Kuhlthau K. Impact of employee benefits on families with children with autism spectrum disorders. Autism. 2016 Jul;20(5):616-22.

Mcguire K, Shui AM, Veenstra-VanderWeele J. Clinical Correlates of Early Generalized Overgrowth in Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):957-8.

Pulcini CD, Perrin JM, Houtrow AJ, Sargent J, Shui A, Kuhlthau K. Examining Trends and Coexisting Conditions Among Children Qualifying for SSI Under ADHD, ASD, and ID. Acad Pediatr. 2015 Jul-Aug;15(4):439-43.

Johnson CR, DeMand A, Shui A. Relationships between anxiety and sleep and feeding in young children with ASD. Journal of Developmental and Physical Disabilities. 2015 June;27(3):359-373.

De Vinck-Baroody O, Shui A, Macklin EA, Hyman SL, Leventhal JM, Weitzman C. Overweight and Obesity in a Sample of Children with Autism Spectrum Disorder. Acad Pediatr. 2015 Jul-Aug;15(4):396-404.

Paganoni S, Hyman T, Shui A, et al. Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis. Muscle Nerve. 2015 Sep;52(3):339-43.

Nicholson K, Paganoni S, Shui A, Schoenfeld D, Sherman A, et al. Urate Levels Predict Disease Progression and Survival in Amyotrophic Lateral Sclerosis (ALS). Neurology. 2015 Apr;84(14 Supplement):P6. 100.

Franklin A, Swanson JB, Shui A, Voigt RG. Effect of parent education on autistic regression in preschool-aged children. J Dev Behav Pediatr. 2015 Feb;36(2):S16-S16.

Atassi N, Berry J, Shui A, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology. 2014 Nov;83(19):1719-25.

Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, Hayden D, Shui A, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lance Neurol. 2014 Nov;13(11):1083-91.

Mazurek MO, Keefer, Shui A, Vasa RA. One-year course and predictors of abdominal pain in children with autism spectrum disorders: The role of anxiety and sensory over-responsivity. Research in Autism Spectrum Disorders. 2014 Nov;8(11):1508-1515.

Johnson CR, Turner K, Stewart PA, Schmidt B, Shui A, et al. Relationships between feeding problems, behavioral characteristics and nutritional quality in children with ASD. J Autism Dev Disord. 2014 Sep;44(9):2175-84.

Ratti E, Berry J, Atassi N, Shui A, et al. Predictors of Outcome in Amyotrophic Lateral Sclerosis. Neurology. 2014 Apr;82(10 Supplement):P2. 076.

Broder-Fingert S, Shui A, Pulcini CD, Kurowski D, Perrin JM. Racial and ethnic differences in subspecialty service use by children with autism. Pediatrics. 2013 Jul;132(1):94-100.

Leitner M, Sherman A, Atassi N, Berry J, Shui A, et al. ALS enters the world of big data: Initial description of and results from the PRO-ACT platform. Neurology. 2013 Feb;80(7 Supplement): P07. 064-P07.064.

Royce-Nagel G, Cudkowicz M, Myers D, Nicholson K, Shui A, Schoenfeld D, Huang X, Brown RH. Vanadium, aluminum, magnesium and manganese are not elevated in hair samples in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010 Oct;11(5):492-3.

Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: Improved survival. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):324-31

Frisch DR, Giedrimas E, Mohanavelu S, Shui A, Ho KK, Gibson CM, Josephson ME, Zimetbaum PJ.  Predicting irreversible left ventricular dysfunction after acute myocardial infarction. Am J Cardiol. 2009 May;103(9):1206-9

Qureshi M, Shui A, Dibernardo AB, Brown RH Jr, Schoenfeld DA, Cudkowicz ME. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008 Dec;9(6):369-74

Cudkowicz ME, Shefner JM, Simpson E, Grasso D, Yu H, Zhang H, Shui A, et al. Arimoclomol dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis. Muscle Nerve. 2008 Jul;38(1):837-44

Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Shui A, et al.Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J. 2008 Apr; 155(4): 725-31.

McLean DS, Ravid S, Blazing M, Gersh B, Shui A, Cannon CP. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. Am Heart J. 2008 Feb;155(2):298-302.

Gibson CM, Pride YB, Buros JL, Lord E, Shui A, et al. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008 Feb;51(5):546-551.    

Qureshi M, Shui A, Dibernardo A, Schoenfeld D, Cudkowicz M. Effects of baseline laboratory values and medication use on disease progression in amyotrophic lateral sclerosis. 18th International Symposium on ALS/MND.Amyotrophic Lateral Sclerosis. 2007 Dec;8(1), pg 111.

Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, et al. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiology. 2007 Dec 15;100(12):1734-8.

Scirica BM, Morrow DA, Sadowski Z, Ruda M, Nicolau JC, Giugliano RP, Wiviott SD, Sabatine MS, Shui A, et al. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. Eur Heart J. 2007 Sep;28(17):2070-6.

Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E. Long-term prognostic value of neopterin. A novel marker of monocyte activation in patients with acute coronary syndrome. Circulation. 2007 Jun 19;115(24):3071-8.

Gibson CM, Haim M, Aroesty JM, Ciaglo L, Shui A, et al. Association of ventricular fibrillation and ventricular tachycardia (VT/VF) with impaired TIMI myocardial perfusion grades (TMPG) even in the presence of normal TIMI grade 3 flow. Circulation. 2006 Oct 31;114(Suppl 18):II_706.

Drummond MF, Schwartz JS, Koren M, Cannon C, Davie A, Shui A, et al. CV3 Cost-effectiveness of intensive statin therapy compared to moderate statin therapy in patients with acute coronary syndrome: analysis from Canada, Germany and the UK. Value in Health - The Journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 2006 Nov-Dec;9(6):A193.

Scirica BM, Morrow DA, Giugliano RP, Wiviott SD, Sabatine MS, Shui A, et al. Enoxaparin reduces recurrent MI and death in patients with STEMI undergoing fibrinolysis who achieve early ST resolution: The ExTRACT-TIMI 25 ECG Study. Circulation. 2006 Oct;114(Suppl 18): II_743-II_743.

Donahoe SM, Steward GC, McCabe CH, Murphy SA, Shui A, et al. The impact of diabetes on mortality in acute coronary syndrome: An analysis of 62,035 patients from the TIMI study group. Circulation. 2006 Oct;114(Suppl 18): II_649-II_649.

Ray KK, Morrow DA, Cannon CP, Sabatine, Shui A, et al. Increased monocyte activation detected by serum neopterin and long-term risk in patients with acute coronary syndromes: Analysis from PROVE IT-TIMI 22. Circulation. 2006 Oct;114(Suppl 18):II_460-II_461.

Ray KK, Morrow DA, Shui A, Rifai N, Cannon CP. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). Am J Cardiology. 2006 Oct 1;98(7):861-5. 

Morrow DA, de Lemos JA, Sabatine MS, Wiviott SD, Blazing MA, Shui A, et al. Clinical relevance of C-Reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial. Circulation. 2006 Jul 25;114(4):281-8.

Deibele AJ, Kirtane AJ, Pinto DS, Lucca MJ, Neva C, Shui A, et al. Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina.  J Thromb Thrombolysis.2006 Aug;22(1):47-50.

Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE-IT-TIMI 22 study. J Am Coll Cardiol. 2006 Jun;47(11):2326-2331.

Ahmed S, Cannon CP, Giugliano RP, Shui A, et al. The independent and combined risks of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2006 Feb;47(4):207A-207A.

Pinto DS, Kirtane AJ, Ruocco NA, Deibele AJ, Shui A, et al. Administration of intracoronary Eptifibatide during ST-elevation myocardial infarction. Am J Cardiology. 2005 Dec 1;96(11): 1494-7.